Page 104 - ARNM-3-1

Advances in Radiotherapy
& Nuclear Medicine PET/CT in B-cell non-Hodgkin’s lymphoma

Author contributions A comparison with conventional imaging techniques.
Research Square [Preprint]; 2024.
Conceptualization: Phuong Pham Cam, Thai Pham Van
Investigation: Thang Nguyen Van, Nien Vu Thi, Phuong doi: 10.21203/rs.3.rs-3837903/v1
Pham Cam, Thai Pham Van 7. Metser U, Prica A, Hodgson DC, et al. Effect of PET/CT on
Methodology: Thang Nguyen Van, Thai Pham Van the management and outcomes of participants with Hodgkin
Writing–original draft: Thang Nguyen Van, Nien Vu Thi, and aggressive non-Hodgkin lymphoma: A multicenter
Phuong Pham Cam registry. Radiology. 2019;290(2):488-495.
Writing–review & editing: Phuong Pham Cam, Thai Pham doi: 10.1148/radiol.2018181519
Van 8. Raanani P, Shasha Y, Perry C, et al. Is CT scan still necessary

Ethics approval and consent to participate for staging in Hodgkin and non-Hodgkin lymphoma
patients in the PET/CT era? Ann Oncol. 2006;17(1):117-122.
This study was approved by Hanoi Medical University doi: 10.1093/annonc/mdj024
(certificate of approval No. 4670/QĐ-ĐHYHN). This
is a retrospective, non-interventional study thus ethics 9. Omar NN, Alotaify LM, Abolela MS. PET/CT in initial
staging and therapy response assessment of lymphoma.
approval is not required.
Egypt J Radiol Nucl Med. 2016;47(4):1639-1647.
Consent for publication doi: 10.1016/j.ejrnm.2016.07.009
Informed consent was obtained from the patients to 10. Barrington SF, Kirkwood AA, Franceschetto A, et al.
publish their data. PET-CT for staging and early response: Results from the
response-adapted therapy in advanced hodgkin lymphoma
Availability of data study. Blood. 2016;127(12):1531-1538.

Not applicable. doi: 10.1182/blood-2015-11-679407
11. Adams HJA, Kwee TC, Keizer B, et al. FDG PET/CT for
References the detection of bone marrow involvement in diffuse large

1. Bray F, Laversanne M, Sung H, et al. Global cancer statistics B-cell lymphoma: Systematic review and meta-analysis. Eur
2022: GLOBOCAN estimates of incidence and mortality J Nucl Med Mol Imaging. 2014;41(3):565-574.
worldwide for 36 cancers in 185 countries. CA Cancer J Clin. doi: 10.1007/s00259-013-2623-4
2024;74(3):229-263.
12. Li Z, Li C, Chen B, et al. FDG-PET/CT versus bone marrow
doi: 10.3322/caac.21834 biopsy in bone marrow involvement in newly diagnosed
paediatric lymphoma: A systematic review and meta-
2. Fueger BJ, Yeom K, Czernin J, et al. Comparison of CT,
PET, and PET/CT for Staging of patients with indolent non- analysis. J Orthop Surg Res. 2021;16(1):482.
Hodgkin’s lymphoma. Mol Imaging Biol. 2009;11(4):269-274. doi: 10.1186/s13018-021-02521-3
doi: 10.1007/s11307-009-0200-9 13. Berthet L, Cochet A, Kanoun S, et al. In newly diagnosed
diffuse large B-cell lymphoma, determination of bone
3. Pham VT, Thieu TH, Mai TK, et al. Evaluate the role of 18F-
FDG PET/CT in diagnosing the stage of non-Hodgkin’s marrow involvement with 18F-FDG PET/CT provides
lymphoma. Vietnam J Oncol. 2018;5:75-79. better diagnostic performance and prognostic stratification
than does biopsy. J Nucl Med. 2013;54(8):1244-1250.
4. Nguyen HT, Nguyen KL, Nguyen HN, et al. The role of
18FDG PET/CT in assessing stage and response to treatment doi: 10.2967/jnumed.112.114710
of malignant non-Hodgkin’s lymphoma. J Milit Med Pharm. 14. Wang D, Huo Y, Chen S, et al. Whole-body MRI versus
2022;6:107-117. 18F-FDG PET/CT for pretherapeutic assessment and
staging of lymphoma: meta-analysis. Onco Targets Ther.
5. Mai HS, Le NH. FDG PET/CT in stage assessment Stage
and response to treatment of extranodal non-Hodgkin 2018;11:3597-3608.
lymphoma. Vietnam J Radiol. 2022;25:58-64. doi: 10.2147/OTT.S148189
doi: 10.55046/vjrnm.25.642.2016 15. Maccioni F, Alfieri G, Assanto GM, et al. Whole
body MRI with diffusion weighted imaging versus
6. Kasireddy S, Nirmal S, Kathal R, et al. A systematic review of
the role of PET-CT imaging in the assessment of treatment 18f-fluorodeoxyglucose-PET/CT in the staging of
response and its predictive value for survival outcomes in lymphomas. Radiol Med. 2023;128(5):556-564.
adult patients with newly diagnosed Hodgkin lymphoma: doi: 10.1007/s11547-023-01622-9

Volume 3 Issue 1 (2025) 96 doi: 10.36922/arnm.4813